Skip to content

Annexon ANNX Return on assets

Return on assets at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
11.3%-1.2pp
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
-27.1%+3.2pp
Omeros logo
OmerosOMER
-48.6%
Vor Biopharma logo
Vor BiopharmaVOR
-1,676.5%-1,749pp
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-45%+18.8pp
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-31%-6.8pp

Other financials

Income statement

See full
Operating income-$46.1M+19.8%
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%
Total assets$262.9M-13.2%

Cash flow

See full
Operating cash flow-$46.8M+6.5%
CapEx--100%
Free cash flow-$46.8M+6.6%

Valuation

See full
Market cap$868.37M+223%
Enterprise value$718.59M+261%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Calculated from Annexon’s reported figures.

Based on trailing twelve months.

The official record: Annexon’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Annexon's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Annexon's return on assets?
Annexon (ANNX) reported return on assets of -69.4% in Q1 2026.
How has Annexon's return on assets changed year-over-year?
Annexon's return on assets decreased by 25.9% year-over-year, from -55.1% to -69.4%.
What is the long-term trend for Annexon's return on assets?
Over 5 years (2020 to 2025), Annexon's return on assets has grown at a 16.1% compound annual growth rate (CAGR), from -31.2% to -65.9%.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.